VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for Xeris Biopharma Holdings Inc Common Stock (XERS)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Xeris Biopharma Holdings Inc Common Stock
Symbol: XERS
Shares outstanding: 165,974,436 shares
Disclosed Ownership: 11,186,677 shares
Ownership: 6.7%
Form type: SCHEDULE 13G/A
Filing time: 30 Jan 2026, 14:43:35 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	6.7%	11,186,677	0	1,339,227	Ashley Grim	Head of Global Fund Administration